876
Participants
Start Date
November 2, 2020
Primary Completion Date
April 30, 2023
Study Completion Date
April 30, 2023
Home-based remote heart failure management
For patients randomized to Group 1, the home-based remote heart failure management system will be connected via the internet for active intervention. In Group 2 patients, the system will not be activated although all data will continue to be stored and reviewed at clinic visits. For patients in Group 1, clinically-assigned targets and alert thresholds of individual physiological parameters including blood pressure, pulse rate, and body weight will be decided before discharge and at entry into the three management modes. Site investigators will review individual patient physiological parameters upon clinic visits, and treatment can be initiated through instant communication (electronic communication and/or phone).
Home-based physiological parameter recording only
For patients randomized to Group 2, the home-based remote heart failure management system will continuously record and store patients information to be reviewed at clinic visits but not connected to internet. Site investigators will review individual patient physiological parameters upon clinic visits, and no treatment will be initiated through instant communication.
The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Island
Collaborators (1)
Chinese University of Hong Kong
OTHER
Novartis Pharmaceuticals
INDUSTRY
Biofourmis Singapore Pte Ltd.
INDUSTRY
The University of Hong Kong
OTHER